comparemela.com

Biotech Acceleration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster

New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and fasterGhent, Belgium, 6 December 2021 – Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert genetic material into cells. T.

Trince Raises €4M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Grapheal Raises EUR1 9 Million to Advance Development of Embedded Biosensing Technology and Application in Digital COVID Testing and Wound Monitoring

Press release content from Business Wire. The AP news staff was not involved in its creation. Grapheal Raises EUR1.9 Million to Advance Development of Embedded Biosensing Technology and Application in Digital COVID Testing and Wound Monitoring February 9, 2021 GMT GRENOBLE, France (BUSINESS WIRE) Feb 9, 2021 Grapheal, a developer of graphene-based embedded biosensors for on-site diagnostics and remote patient monitoring, announced today that it has raised a total of EUR1.9 million in equity and non-dilutive sources, including seed financing from Novalis Biotech’s Acceleration Fund, several innovation grants, and Bpifrance convertible notes and loans. ADVERTISEMENT The funds will be used to advance the industrialization of Grapheal’s flexible graphene-based biosensor technology. This sensing technology combines novel electronic nanomaterials, embedded wireless electronics, software data analysis, and medical cloud IoT technologies. The first two applications of the technolo

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.